Curative Ventures
Dallas biotech investor led by Bronson Crouch; backer and incubator of Instil Bio, iTeos, TCR2, Peloton.
VC
Sector Specialist
📍 Dallas, TX
Founded 2010
AUM
Not Disclosed
Strategic / Balance-Sheet
PRIVATE
Curative Ventures is a Dallas-based capital and talent partner to category-defining biotech companies developing new therapies, led by Managing Partner Bronson Crouch, who also serves as Chairman and CEO of portfolio company Instil Bio. Its investments include Instil Bio (IPO 2021), TCR2 Therapeutics (IPO 2019), iTeos Therapeutics, Peloton Therapeutics (acquired by Merck in 2019) and CoStim Pharmaceuticals (acquired by Novartis).
Portfolio Companies (5)
Instil BioiTeos TherapeuticsTCR2 TherapeuticsPeloton TherapeuticsCoStim Pharmaceuticals
Investment Focus
Stages
Seed · Series A · Series B · Growth
Sectors
Bio · Healthcare · Oncology
VCSector SpecialistSJ Top 100
Investor data reflects publicly disclosed AUM, fund sizes, and portfolio holdings as of recent date. Refreshed periodically.